NCT05625750Recruiting
Observational Study About Patients Diagnosed With NAFLD
Study on the Characteristic, Therapy and Prognosis of Patients With Nonalcoholic Fatty Liver Disease
Source: ClinicalTrials.gov · Last updated 30 Nov 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Nonalcoholic fatty liver disease (NAFLD) is the most common condition affecting the liver, owing to its association with obesity and the metabolic syndrome. The largest study to date using magnetic resonance spectroscopy to quantify liver triglyceride (TG) content showed that approximately 33% of individuals have hepatic steatosis. NAFLD encompasses a continuum of histological findings that starts with steatosis that can progress to nonalcoholic steatohepatitis (NASH), which is characterized by inflammation and cell death, and eventually cirrhosis. Given the large number of individuals afflicted with this condition, there is a clear need to develop effective and safe therapies to treat NAFLD.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 15 Nov 2022
- Start date
- 27 Apr 2022
- Primary completion date
- 27 Apr 2025
- Lead sponsor
- Xiangya Hospital of Central South University
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT05625750
What you commit to
- Study type: Observational
- Planned participants: 500
- From 27 Apr 2022 to the primary completion date, 27 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- malignant tumors, dementia, active tuberculosis, AIDS, organ failure, pregnancy or breastfeeding, etc cannot cooperate with the investigation
- incomplete data such as HBV serological results and abdominal ultrasound results
Other
- patients suspected of excessive alcohol consumption
- patients who refuse to sign informed consent
Who the study is looking for
- 1\. patients diagnosed with nonalcoholic fatty liver disease
Age in the registry: 18 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Infectious Disease, Xiangya Hospital, Central South University Coordinator of this site? Confirm its status | Changsha | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.